How does it feel?
Comfrey is a highly mucilaginous herb, and simply breaking open a fleshy leaf will reveal slimy mucilage seeping out. Experientially, we can get to know a lot about comfrey herb just by observing, touching and smelling it.
Visually, comfrey has big, green, plump, luscious leaves which look nutritious and are filled with fluid. The smell of the leaf is fresh, slightly salty, cucumber-like and mildly sweet, indicating the mineral and polysaccharide content. As you break up a leaf and roll it in your hands it becomes moist and mucilaginous, revealing the high content of polysaccharides. It feels cooling and soothing, reflecting the energetics and anti-inflammatory properties which draw heat from inflammations (1). As the plant’s mucus dries on the skin it feels tacky and tightened, due to the high tannin content, which is astringent and toning for surfaces and mucous membranes.
Made into a leaf infusion the smell is strong, salty, seaweed-like and slightly sweet, linking to the nourishing minerals and polysaccharides. The taste is much blander than the smell; slightly salty, sweet, bitter and astringent. The sweetness is from the abundant polysaccharides, the bitterness from the alkaloids and the astringency from the tannins (1).
What can I use it for?
Comfrey is a potent tissue healer of the skin, connective tissues and bone (2). It is now recommended for external use only, as it contains potentially toxic constituents called pyrrolizidine alkaloids (PAs) (3). See the section on safety (below).
Comfrey is a primary first aid remedy for wounds, cuts, abrasions, burns, scalds, sunburn, skin irritations and rashes (4,5). It has a soothing and cooling effect. The cell-healing action of some of the constituents, notably allantoin which rapidly moves through the tissues, speeds up wound healing and reduces the production of scar tissue (6).
There is a wealth of clinical research demonstrating the efficacy and safety of comfrey preparations for topical treatment of painful muscle and joint complaints including pain, inflammation and swelling of muscles and joints in degenerative arthritis; acute myalgia (muscle pain); sprains, contusions and strains after sports injuries and accidents (7,8).
Into the heart of comfrey
Comfrey is cooling, moistening, and slightly constricting (9,10,11). Energetically and emotionally, comfrey relates to the base chakra; where energy is stored (12). Comfrey is for those who lack structure and form in their lives, who need to develop a solid base, to give a sense of order where chaos is felt (12). Comfrey is a powerful healer of raw and sensitive emotional wounds and trauma, providing a soothing and grounding protective layer while the person heals (12). Comfrey also confers determination, cohesiveness, and the ability to fuse back together what has come apart, while encouraging growth and change (2,13).
I can see no evidence for the classic proving of the homeopathic use of comfrey and I guess it is just a commercial enterprise. I vote to exclude this sentence.
Traditional uses
Comfrey has a long history of use in healing wounds, injured tissues, and broken bones; and many of the common names allude to these virtues (14). Parkinson recommended that the fresh roots were “bruised, beaten small and laid on leather” to be applied externally to broken bones, fresh wounds, gout, painful joints, ulcers, and gangrene (11). A decoction of the root was used externally for mastitis and bleeding haemorrhoids, while the internal applications were for ailments of the lungs to help expectorate mucus and heal ulcers in those who are coughing up blood (11).
The earlier traditions of internal use largely stemmed from the effect of the mucilaginous agents on mucous tissues of the lungs and digestive tract (15). A strong decoction of the root, drunk ad libitum, was used for pneumonia, quinsy, whooping cough, to relieve breathing difficulty and to aid expectoration, especially in cases of bleeding in the lungs (14,16). Comfrey root, boiled in water, or made into a wine or syrup was used for diarrhoea, dysentery, bronchial irritation, coughs, haemoptysis, leucorrhoea, female debility, and passive haemorrhages from the bowels, kidneys, or womb (15). These were taken in doses of 1 to 4 fluid ounces (30–100ml), 2–3 times a day. (15).
The young leaves were eaten as a green vegetable and used to flavour cakes, while the roots were used together with chicory and dandelion root as a coffee alternative (14).
It should be noted that since the discovery of pyrrolizidine alkaloids, constituents with known toxicity risks, that can cause veno-occlusive liver disease in susceptible individuals, many of the traditional herbal uses of the comfrey have come into question (11) The delayed nature of this potential toxicity means that it is unlikely to have been spotted in earlier practice and now we cannot exclude the possibility that this happened. See the section on safety below.
Traditional actions
Herbal actions describe therapeutic changes that occur in the body in response to taking a herb. These actions are used to express how a herb physiologically influences cells, tissues, organs or systems. Clinical observations are traditionally what have defined these actions: an increase in urine output, diuretic; improved wound healing, vulnerary; or a reduction in fever, antipyretic. These descriptors too have become a means to group herbs by their effects on the body — herbs with a nervine action have become the nervines, herbs with a bitter action are the bitters. Recognising herbs as members of these groups provides a preliminary familiarity with their mechanisms from which to then develop an understanding of their affinities and nuance and discern their clinical significance.
Traditional energetic actions
Herbal energetics are the descriptions Herbalists have given to plants, mushrooms, lichens, foods, and some minerals based on the direct experience of how they taste, feel, and work in the body. All traditional health systems use these principles to explain how the environment we live in and absorb, impacts our health. Find out more about traditional energetic actions in our article “An introduction to herbal energetics“.
What practitioners say
Skin
The therapeutic properties of comfrey are based on its tissue healing, astringent, anti-inflammatory, and analgesic effects when applied directly to the skin (7). Due to the PA content of comfrey and the associated potential hepatotoxicity, the safest means of taking this herb is via external application. The skin absorption of PAs is low, while the other therapeutic constituents are freely absorbed (3).
Comfrey stimulates granulation and tissue regeneration and prevents scar tissue formation, making it an excellent remedy for any type of skin damage (7). Allantoin and rosmarinic acid are implicated in the pharmacodynamic effects of comfrey (7). Allantoin is a potent cell-proliferator, which stimulates the growth of healthy tissue, speeds wound-healing and reduces scar formation (6,17). Rosmarinic acid has anti-inflammatory, anti-viral and anti-bacterial activity (3,17). In addition to the action of allantoin and the phenols, the mucilaginous polysaccharides have a local anti-inflammatory and soothing action (18). There are also high levels of astringent tannins that will help heal surface damage. This makes comfrey ideal for topical applications to the skin for bruises, swellings, irritable skin lesions, wounds, ulcers, insect bites, eczema and psoriasis (10,18,19). Allantoin is highly soluble in hot water, somewhat soluble in oil, and only slightly soluble in alcohol extracts (17). For this reason, comfrey works well as a poultice, compress, soak or wash for wounds, external ulcers, burns, eczema, acne, psoriasis and chronic varicose ulcers (2,6). Human clinical and observational studies have identified the efficacy of external comfrey preparation for acne, psoriasis, atopic dermatitis and venous leg ulcers (21).
Musculoskeletal
Bone
Comfrey is one of the best herbs to support bone healing from fractures and breaks, due to the combination of the minerals, the healing properties of allantoin, and the anti-inflammatory action. Allantoin is a remarkable cell proliferator that stimulates the production of collagen, connective tissue, cartilage and bone (4).
Soft-tissue
The anti-inflammatory, analgesic and healing properties of comfrey can be applied to heal soft-tissue injuries such as sprains, bruises, pulled muscles, ligament strains; and myalgia (muscle pain) (19,33,34). The topical application of comfrey has been shown to have an anti-inflammatory and analgesic action which improves pain and functional movement in acute myalgia (22). In acute ankle sprains, comfrey ointment has been shown to reduce pain and ankle oedema, and improve ankle mobility (23), with a superior analgesic effect to diclofenac (24,25).
Joints
Comfrey reduces inflammation and pain in joint conditions such as osteoarthritis, degenerative arthritis and gout (19,33,34). In addition to the actions of allantoin, phenols and mucilage, the silica in comfrey affects both soft and firm structures in the human body, having a firming effect on soft connective tissue and strengthening and stabilising joints and ligaments (13). Comfrey root extract ointment has been clinically demonstrated to reduce pain, improve mobility and increase quality of life in knee osteoarthritis (26). Additionally, two observational studies identified that two weeks of topical treatment with comfrey root preparations reduced joint pain by 50% and completely eliminated morning stiffness in osteoarthritis (26). In addition to working well as an ointment for musculoskeletal conditions, comfrey works well as a warm compress, as the mucilage retains the heat and allows the heat to penetrate the tissues more progressively (18).
Gastrointestinal
Due to concerns about hepatotoxicity the internal use of comfrey is no longer recommended. However before these potential long-term risks were identified it was used in the gastrointestinal tract for its wound-healing, analgesic, astringent and soothing effects and some practitioners still reserve it for the short term only (3). The mucilaginous polysaccharides produce a mucous coating which soothes and protects exposed or irritated surfaces of the gastrointestinal tract (18). The astringent tannins can stop bleeding and protect the surface membranes against inflammation and infection (4). Comfrey has therefore been used in the treatment of gastric and duodenal ulcers, gastric reflux, oesophagitis, ulcerative colitis and hiatus hernia (6,18).
Herbal alternatives to comfrey to support mucous membrane healing and treat gastric ulcers, gastritis and gastrointestinal inflammations include slippery elm bark (Ulmus fulva), marshmallow root (Althaea officinalis), liquorice (Glycyrrhiza glabra), plantain (Plantago lanceolata) and meadowsweet (Filipendula ulmaria) (4,6).
Research
A critical scoping review in 2013 evaluated the clinical evidence to support the external uses of comfrey (21). The authors concluded that there is robust evidence of benefit for ankle distortions (sprains), back pain, abrasion wounds and osteoarthritis (21).
Wound-healing
Barna carried out a randomised-controlled, double-blind clinical study on 278 patients with fresh skin abrasions. Topical application of a comfrey ointment (10% extract) was compared to a lower dose, reference preparation (1% extract). After 2–3 days there was a significantly faster reduction in the wound area with the 10% extract, and a complete healing time that was three days faster than the 1% extract. The authors concluded that comfrey ointment extract can contribute to significant wound-healing effects (20).
Muscle pain/myalgia
Kucera et al. assessed the effectiveness of two strengths of topical comfrey cream (10% vs 1%) in 215 patients with myalgia. Participants in both groups applied 2–3 g of cream three times per day, for 8–10 days to their affected pain area. Pain in motion, pain at rest, and pain on palpation all decreased in both groups, and this effect was significantly greater for the 10% cream. The authors concluded that the study confirms the anti-inflammatory and analgesic effects of topical comfrey application for muscle pain (22).
Osteoarthritis
Grube et al. carried out a randomis ed, double‐blind, placebo-controlled trial of 220 patients with painful osteoarthritic knee. Three times a day for 21 days the patients applied 2 g comfrey root cream (35% of a 1:2 extract, equivalent to 17.5 g comfrey root per 100 g) or placebo cream. Pain at rest and during movement decreased significantly more in the comfrey group (54.7%) compared to the placebo (10.7%). Pain, stiffness and function symptoms were reduced by 58.0% in the comfrey group, which was significantly greater than the placebo (14.1%). Knee mobility and quality of life significantly increased in the comfrey group. The authors concluded that comfrey root extract ointment is well suited for the treatment of knee osteoarthritis by reducing pain, improving mobility and increasing quality of life (26).
Sprains
142 patients with a unilateral acute ankle sprain took part in a double-blind, randomised, placebo-controlled study (23). A comfrey extract ointment (35% of a 1:2 extract, equivalent to 17.5 g comfrey root per 100 g) or placebo, was applied at 2 g, four times per day, for 7—9 days. The comfrey treatment significantly reduced pain and ankle oedema, and significantly improved ankle mobility compared to the placebo (23).
A randomised, parallel-group study enrolled 164 patients with an acute, unilateral ankle sprain (24). Four times per day, for 7 days they applied 2 g of either comfrey ointment (35% 1:2 extract, equivalent to 17.5 g comfrey root per 100 g), or diclofenac gel. The improvement in tenderness to pressure was superior in the comfrey group. Pain at rest decreased by 92% and 85% in the comfrey and diclofenac groups, respectively, and pain during movement decreased by 83% and 72% for the comfrey and diclofenac groups, respectively. There was a slightly greater, but not significantly different reduction in pain in the comfrey group, meaning the comfrey had a comparable analgesic effect to the diclofenac (24). A later study re-evaluated the data and concluded that comfrey ointment was statistically superior to diclofenac (25).
Did you know?
Comfrey makes a great plant fertiliser by soaking the leaves in water to make a liquid feed for nourishing poor-quality soil or feeding fruit and vegetables during the fruiting season (27,28). The fresh leaves also speed up composting and can be used as mulch around other plants in the growing season (27).
Additional information
Botanical description
There are several hybrids of the native common comfrey, which are all perennial with rough, hairy leaves and stem, broad lanceolate leaves along a long stalk (27,39). The bell-shaped flowers are in spikes which are coiled in a spiral at first (27,39).
Common comfrey (Symphytum officinale) is a tall, deciduous, perennial herb growing to about 1.5 m tall (28). It forms a clump of erect stems bearing coarse, hairy dark green leaves up to 25 cm in length, from April to October (28,39). The upper stem leaves run down the stem to the next leaf junction, creating the winged stem (39). The tubular flowers with long sepal teeth form in clusters, they are creamy-yellow/pink/ pale purple, 2 cm in length, appearing in late spring and summer, from May to July (28,39,40).
The most common hybrid in the UK is Russian comfrey (Symphytum × uplandicum) which is a hybrid of S. asperum and S. officinale (27,39,40). Russian comfrey can be differentiated from common comfrey by the bright blue/violet flowers, narrower leaves, and shorter winged sections which end between the leaves (39,40). Russian comfrey is much higher (up to five times) in the hepatotoxic PAs than common comfrey, which is important to consider when growing, harvesting and using comfrey as herbal medicine (11).
Common names
- Common comfrey
- Consound
- Healing herb
- Knitbone
- Slippery-root
- Black root
- Bohemian comfrey
- Gum plant
- Knit-back
- Bruisewort
- Church-bells
- Saracen’s root
Safety
Comfrey contains potentially hepatotoxic pyrrolizidine alkaloids (PA), found in especially high concentrations in the roots (29). During the process of breakdown in the liver, some types of PAs are converted to toxic by-products called pyrroles, which can damage the hepatic tissue (3,30). Human hepatotoxicity from PA-containing plants is well documented, and several cases of human poisoning have been reported for comfrey (3,17,29,31). Acute toxicity results in hepatic necrosis, whereas chronic toxicity results in veno-occlusive disease characterised by enlarged liver cells (3). Regulatory bodies and practitioners widely recommend that comfrey should be restricted to external use only. Some herbal practitioners reserve the use of the leaf for internal use, for a limited duration.
- The European Medicines Agency does not permit comfrey for internal use and external use is restricted to adults only, for a maximum duration of 10 days, and the PA content of the preparation must not exceed 0.35 mcg per day (32).
- The American Botanical Council have approved use of both leaf and root for external use only, restricted to a daily dose 100 mcg, for no longer than 4—6 weeks per year (33,34)
- In Australasia comfrey cannot be legally prescribed for internal use (8).
- In the UK, the National Institute of Medical Herbalists (NIMH) has imposed a self-regulated ban to restrict comfrey root to external use only, and a self-regulated restriction on comfrey leaf to 100 ml (1:5) tincture internal use for a maximum of six weeks.
Interactions
Comfrey should not be taken at the same time as herbs or medications which induce CYP3A liver enzymes, including St John’s wort, schisandra and epilepsy medications (35). Induction of phase 1 liver metabolism (specifically CYP3A), speeds the conversion of PAs to the activated toxic pyrroles (30,35). Conjugation of the pyrroles in phase 2 liver metabolism is the rate-limiting step of detoxification, and induction of phase 1 metabolism increases the potential for hepatic cell injury (30).
Comfrey should not be taken alongside other medications requiring phase 2 liver metabolism, especially those requiring glutathione conjugation, since PA-induced hepatotoxicity may be more pronounced if the glutathione content in the liver is low (30).
Due to the risk of additive toxicity, comfrey should not be taken alongside other PA-containing herbs or supplements, including boneset, borage, butterbur, coltsfoot, gravel root, hemp agrimony, and tansy (36).
Contraindications
There are additional reasons not to use comfrey internally for those with a history of liver disease due to the potential hepatotoxicity from the pyrrolizidine alkaloids (29).
The same applies to any stage of pregnancy and in breastfeeding as hepatotoxic PAs can be fatal to the foetus and potentially harmful to the infant. (29). Neither should it be taken by children under the age of 18 years old (29,35).
Preparations
- Infusion
- Tincture
- Topical applications
Dosage
Topical
- Ointment/cream/oil: 5–30% root extract, applied three times a day (3,19)
- Poultice: Crushed fresh root or leaf (9, 33,34)
- Compress: Infusion or decoction of root or leaf (9)
- Wash/soak: Infusion or decoction of leaf or root (9)
PAs are water-soluble and will be more highly concentrated in water extracts, whereas oil extracts contain lower concentrations of the potentially toxic PA constituents (17). The skin absorption of the PAs present in comfrey is reported to be low, however, use should be limited to the minimum effective dose, particularly in the case of broken skin (3,35).
Licensed, commercial herbal products intended for internal use are not permitted to contain comfrey (3,32). Commercial products intended for topical application are restricted to 10-day continuous use (3,32).
Plant parts used
- Leaf
- Root (external only)
Internal use of the leaf is generally restricted by regulating bodies, and the root is for external use only, see the section on safety, above.
Constituents
- Pyrrolizidine alkaloids* (0.02–1.2%): Symphytine, symlandine, echimidine, intermidine, lycopsamine, myoscorpine, acetyllycopsamine, acetylintermidine, lasiocarpine, heliosupine, viridiflorine, and echiumine (3,7)
- Allantoin 0.75–4.7% (3,7,37)
- Polysaccharides (up to 29%): Gum (arabinose, glucuronic acid, mannose, rhamnose, xylose); mucilage (glucose, fructose) (3,7)
- Tannins: 2.4–6% (3, 37)
- Triterpenes: Sitosterol and stigmasterol (phytosterols), steroidal saponins and isobauerenol (3)
- Phenolics and their glycosides: Rosmarinic acid (0.2%), caffeic acid (0.004%), chlorogenic acid (0.012%), lithospermic acid (3,7,17)
- Phytosterols: β-sitosterol, sigmasterol (37)
- Other constituents: Protein, carotene (0.63%), choline, silica, calcium, vitamin A, vitamin B12, Vitamin C, iron, potassium, magnesium, selenium (3,5,37)
*The concentration of PAs is higher in the roots (0.25–0.29%) than leaves (0.02–0.18%), with the young leaves having higher value than the mature leaves (17).
Habitat
The native distribution is across Europe and UK, and is widely naturalised across North America, parts of South America and temperate Asia (41,42). Comfrey often forms extensive colonies and can be found in wetland areas such as damp grassland, riverbanks, streambanks, canal sides, ditches, bogs, marshes, swamps, peatlands and damp road verges (39,40,42).
Sustainability
Comfrey is not listed by the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES), therefore is not subject to any trading controls (44).
Comfrey has not been ranked by Nature Serve since it is common and well distributed across North America, and does not appear on the U.S. Endangered Species act (45). Comfrey is not on the United Plant Savers “to watch” list (46).
The International Union for Conservation of Nature (IUCN) globally assessed Symphytum officinale in 2012 and lists it as “Least Concern”. They state that the species is widely distributed and abundant in many parts of Europe, with stable subpopulations, and there are currently no known threats to this species (42).
The Vascular Plant, Red Data List for Great Britain lists comfrey as least Concern (LC), meaning it has been evaluated against the criteria and does not qualify as critically endangered, endangered, vulnerable or near threatened (43).
Habitat loss and over-harvesting from the wild are two of the biggest threats faced by medicinal plant species. There are an increasing number of well-known herbal medicines at risk of extinction. We must, therefore, ensure that we source our medicines with sustainability in mind.
The herb supplement industry is growing at a rapid rate and until recent years a vast majority of medicinal plant produce in global trade was of unknown origin. There are some very real and urgent issues surrounding sustainability in the herb industry. These include environmental factors that affect the medicinal viability of herbs, the safety of the habitats that they are taken from, as well as the welfare of workers in the trade.
The botanical supply chain efforts for improved visibility (transparency and traceability) into verifiably sustainable production sites around the world is now certificated through the emergence of credible international voluntary sustainability standards (VSS).
Read our article on Herbal quality and safety: What to know before you buy and Sustainable sourcing of herbs to learn more about what to look for and questions to ask suppliers about sustainability.
Quality control
Herbal medicines are often very safe to take; however, their safety and efficacy can be jeopardised by quality issues. So, it is important to buy herbal medicines from a reputable supplier, from sources known to test their herbs to ensure there is no contamination, adulteration or substitution with incorrect plant matter, as well as ensuring that recognised marker compounds are at appropriate levels in the herbs.
Some important quality assurances to look for are certified organic labelling, the correct scientific/botanical name, and the availability of information from the supplier about ingredient origins. A supplier should be able to tell you where the herbs have come from, what contaminants are not in the herb, and what the primary compounds are.
How to grow
Propagation can be either by division of the roots in spring, root cuttings in early winter, or seed sown in pots in a cold frame in autumn or spring, though the germination of seeds is slow and erratic (27,28). Comfrey grows well in moderately fertile, moist soil in sun or partial shade, though it can grow vigorous once established, with the potential to become a nuisance (28).
Recipe
Healing balm
This anti-inflammatory and healing balm is ideal for broken bones, sprains and strains, muscles and joint aches.
Ingredients
- 75 ml comfrey leaves and root infused oil – Find out how to make infused oils on our page How to make herbal oils.
- 25 ml arnica-infused oil
- 10 g beeswax
- 10 drops wintergreen essential oil
- 5 drops rosemary essential oil
Method
- Heat the infused oil and beeswax in a bain-marie, until the wax has melted.
- Remove from the heat and allow to cool for 5–10 minutes before stirring in the essential oils.
- Pour into a sterilised jar and allow to cool before adding the lid.
- Label and store in a cool, dark place for use within a year.
- Massage into the area required three times per day.
References
- Maier K. Energetic Herbalism: A Guide to Sacred Plant Traditions Integrating Elements of Vitalism, Ayurveda, and Chinese Medicine. Chelsea Green Publishing; 2021.
- Jones, L. A Working Herbal Dispensary: respecting herbs as individuals. Aeon; 2023.
- Barnes, J., Anderson, L.A. and Phillipson, J.D. Herbal medicines: a guide for healthcare professionals: Third Edition. Pharmaceutical press; 2007.
- McIntyre, A. The Complete Herbal Tutor: The Definitive Guide to the Principles and Practices of Herbal Medicine. Aeon Books, 2019.
- Mars, B. The Desktop Guide to Herbal Medicine. Basic Health Publications Inc; 2007.
- Hoffman D. Medicinal Herbalism, The Science and Practice of Herbal Medicine. Healing Arts Press; 2003.
- Staiger C. Comfrey: a clinical overview. Phytotherapy Research. 2012;26(10):1441-8. https://doi.org/10.1002/ptr.4612
- Thomsen M. The Phytotherapy Desk Reference: 6th Edition. 6th ed. Aeon Books; 2022.
- Easley T, Horne S. The Modern Herbal Dispensatory: A Medicine-Making Guide. North Atlantic Books; 2016.
- Wood M. The Earthwise Herbal Volume 1: A Complete Guide to New World Medicinal Plants. North Atlantic Books; 2008.
- Burton-Seal, J. and Seal, M. The Herbalist Bible: John Parkinson’s Lost Classic Rediscovered. Merline Unwin Books; 2014.
- Brooke, E. An Astrological Herbal for Women. The Crossing Press; 1995.
- Fischer-Rizzi, S. Complete Earth Medicine Handbook. Sterling Publishing; 1996.
- Grieve M, Leyel CF, Marshall M. A Modern Herbal. the Medicinal, Culinary, Cosmetic and Economic Properties, Cultivation and Folk-Lore of Herbs, Grasses, Fungi, Shrubs & Trees with All Their Modern Scientific Uses. Dover Publications; 1982.
- Felter H. W, Lloyd J. U. Kings American Dispensary; 18th Edit; 1898. Reprinted on Henriettas Herbpages. Accessed September 21, 2024. https://www.henriettes-herb.com/eclectic/kings/symphytum.html
- Ellingwood, F. The American Materia Medica, Therapeutics and Pharmacognosy; Reprinted on Henritttas Herbpages. Accessed September 21, 2024. https://www.henriettes-herb.com/eclectic/ellingwood/symphytum.html
- Ganora, L. Herbal Constituents: Foundations of Phytochemistry. Herbalchem Press; 2009.
- Pengelly A. The constituents of medicinal plants: an introduction to the chemistry and therapeutics of herbal medicine. CABI Publishing; 2004.
- Bone K. The Ultimate Herbal Compendium: a desktop guide for herbal therapists. Phytotherapy Press; 2007.
- Barna M, Kucera A, Hladícova M, Kucera M. The wound-healing effect of a Symphytum herba extract cream (Symphytum× uplandicum Nyman): results of a randomized, controlled double-blind study. Wiener Medizinische Wochenschrift. 2007;21(157):569-74.
- Frost R, MacPherson H, O’Meara S. A critical scoping review of external uses of comfrey (Symphytum spp.). Complementary therapies in medicine. 2013;21(6):724-45. http://dx.doi.org/10.1016/j.ctim.2013.09.00
- Kucera M, Barna M, Horácek O, Kálal J, Kucera A, Hladíkova M. Topical symphytum herb concentrate cream against myalgia: a randomized controlled double-blind clinical study. Advances in therapy. 2005;22:681-92. https://doi.org/10.1007/BF02849961
- Koll R, Buhr M, Dieter R, Pabst H, Predel HG, Petrowicz O, Giannetti B, Klingenburg S, Staiger C. Efficacy and tolerance of a comfrey root extract (Extr. Rad. Symphyti) in the treatment of ankle distorsions: results of a multicenter, randomized, placebo-controlled, double-blind study. Phytomedicine. 2004;11(6):470-7. https://doi.org/10.1016/j.phymed.2004.02.001
- Predel, H. G., Giannetti, B., Koll, R., Bulitta, M., & Staiger, C. Efficacy of a comfrey root extract ointment in comparison to a diclofenac gel in the treatment of ankle distortions: results of an observer-blind, randomized, multicenter study. Phytomedicine (Stuttgart). 2005; 12(10), 707–714. https://doi.org/10.1016/j.phymed.2005.06.001
- D’Anchise R, Bulitta M, Giannetti B. Comfrey extract ointment in comparison to diclofenac gel in the treatment of acute unilateral ankle sprains (distortions). Arzneimittelforschung. 2007 Nov;57(11):712-6. DOI: 10.1055/s-0031-1296672
- Grube B, Grünwald J, Krug L, Staiger C. Efficacy of a comfrey root (Symphyti offic. radix) extract ointment in the treatment of patients with painful osteoarthritis of the knee: results of a double-blind, randomised, bicenter, placebo-controlled trial. Phytomedicine. 2007;14(1):2-10. https://doi.org/10.1016/j.phymed.2006.11.006
- McVicar, J. Jekka’s Complete Herb Book. Kyle Cathie Limited; 2009.
- Royal Botanical Gardens Kew. Symphytum officinale L. Plants of the Word Online (POWO). Accessed September 20, 2024. https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:120815-1
- Brinker, FJ. Herbal Contraindications & Drug Interactions: Plus Herbal Adjuncts with Medicines. Eclectic Medical Publications, 2010.
- Fu, PP, Xia Q, Lin G, Chou MW. Pyrrolizidine alkaloids—genotoxicity, metabolism enzymes, metabolic activation, and mechanisms. Drug metabolism reviews. 2004;36(1):1-55. https://doi.org/10.1081/DMR-120028426
- Avila C, Breakspear I, Hawrelak J, Salmond S, Evans S. A systematic review and quality assessment of case reports of adverse events for borage (Borago officinalis), coltsfoot (Tussilago farfara) and comfrey (Symphytum officinale). Fitoterapia. 2020;142:104519.https://doi.org/10.1016/j.fitote.2020.104519
- European Medicines Agency. European Union herbal monograph on Symphytum officinale L., radix. Created 31 January 2024. Accessed 21 September, 2024. https://www.ema.europa.eu/en/medicines/herbal/symphyti-radix
- Blumenthal M, Busse WR. Comfrey herb and leaf. In: The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council; 1999. Accessed September 21, 2024. https://www.herbalgram.org/resources/commission-e-monographs/monograph-approved-herbs/comfrey-herb-and-leaf
- Blumenthal M, Busse WR. Comfrey root. In: The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. American Botanical Council; 1999. Accessed September 21, 2024. https://www.herbalgram.org/resources/commission-e-monographs/monograph-approved-herbs/comfrey-root/
- Tobyn, G., Denham, A., Whitelegg, M., Kingsbury, S. & Rowling, M. The Western Herbal Tradition: 2000 Years of Medicinal Plant Knowledge: Jessica Kingsley Publishers; 2016.
- Natural Medicines Professional Database. Therapeutic Research Centre. Comfrey Professional Monograph. Published Nov 16, 2023. Accessed September 21, 2024. https://naturalmedicines.therapeuticresearch.com/
- Fisher C. Materia Medica of Western Herbs. Aeon Books; 2018.
- National Institute of Medical Herbalists (NIMH). https://nimh.org.uk/
- Blamey M, Fitter R, Fitter AH. Wild Flowers of Britain and Ireland: 2Nd Edition. A & C Black; 2013.
- Leaney, RM and Welch, D. Symphytum officinale L. in BSBI Online Plant Atlas 2020, eds P.A. Stroh, T. A. Humphrey, R.J. Burkmar, O.L. Pescott, D.B. Roy, & K.J. Walker. Accessed September 20, 2024. https://plantatlas2020.org/atlas/2cd4p9h.m5c
- Royal Horticultural Society. Symphytum officinale: common comfrey. Accessed September 20, 2024. https://www.rhs.org.uk/plants/17886/symphytum-officinale/details
- Khela, S. Symphytum officinale (Europe assessment). The IUCN Red List of Threatened Species2012: e.T202969A2758315. Accessed on 20 September 2024. https://www.iucnredlist.org/species/202969/2758315
- Cheffings C, Farrell L, (eds), Dines, T.D., Jones, R.A., Leach, S.J., McKean, D.R., Pearman, D.A., Preston, C.D., Rumsey, F.J., Taylor, I. The Vascular Plant Red Data List for Great Britain. Species Status No. 7. Joint National Conservation Committee. 2005. Accessed 20 September, 2024. https://hub.jncc.gov.uk/assets/cc1e96f8-b105-4dd0-bd87-4a4f60449907
- Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES). Accessed September 20, 2024. https://checklist.cites.org/#/en
- NatureServe explorer. Symphytum officinale: common comfrey. Natureserve.org. Accessed September 20, 2024. https://explorer.natureserve.org/Taxon/ELEMENT_GLOBAL.2.157243/Symphytum_officinale
- United Plant Savers. UpS list of herbs & analogs. Published May 14, 2021. Accessed September 20, 2024. https://unitedplantsavers.org/ups-list-of-herbs-analogs/